China's ‘green great wall' eases desertification but triggers hay fever misery: scientists
He has suffered from hay fever – an allergic condition triggered by inhaling pollen – for many years. His symptoms have gradually worsened since 2018, progressing from sneezing and conjunctivitis to an allergic cough and, eventually, bronchial asthma.
The artemisia plant, which is widely cultivated in northwestern China
to contain wind and sand erosion , has been identified as the trigger for his symptoms. Its pollen is particularly active from late summer to mid-autumn.
01:28
Great wall of Taklamakan: China surrounds its largest desert with green belt
Great wall of Taklamakan: China surrounds its largest desert with green belt
This resilient plant contributes to the '
green great wall ' – the weapon across the arid northern region that China uses to fight desertification – but it is also suspected of causing an increasingly concerning endemic hay fever outbreak.
Now, after years of research, a group of Chinese scientists have confirmed the plant's role in causing the disease at a molecular level and identified several allergenic substances in its pollen.
For the first time, the team has identified five volatile components from a member of the artemisia plant family, confirming they could all trigger allergic reactions. These findings 'provide a basis' for preventing and treating allergic diseases in areas where the plants are grown, according to a report in the state-owned newspaper Science Daily on Monday.
The study, which was conducted jointly by scientists from the school of pharmacy at Xian Jiaotong University and the Yulin Forestry Science Research Institute – both in northwestern China's Shaanxi province – was published in the Journal of Hazardous Materials at the end of May.
Artemisia, which has more than 100 species, is easy to grow and has low cultivation costs. However, according to a 2023 report by the Health Times, a subsidiary of People's Daily, its pollen has become a common allergy cause in northern China.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
13 hours ago
- South China Morning Post
Alibaba, Beijing United Family Hospital partner to use AI in cancer diagnosis, treatment
The collaboration will leverage Damo Academy's medical artificial intelligence system, called 'One Sweep Multi-Check', as part of efforts to offer multi-disease AI screening services to the public, according to Monday's statement from Hangzhou -based Alibaba, owner of the South China Morning Post. 'We look forward to working with Damo Academy to drive the health management gateway for cancer and chronic diseases ever forward with cutting-edge AI screening technology,' BJU president Pan Zhongying said in the statement. She pointed out that the AI-based screening system would 'provide more efficient, reliable and people-centred healthcare'. The collaboration with BJU – a full-service, internationally accredited healthcare provider – showed how far Alibaba's research arm has bolstered the credentials of its AI-powered cancer detection tools. Damo Academy's AI screening system, which can identify a variety of diseases through a single flat computed tomography (CT) scan, provides a quick and low-cost solution to the growing problem of cancer diagnoses. According to 2024 estimates from the World Health Organization , global cancer diagnoses are expected to top 35 million by 2050. The facade of Beijing United Family Hospital in the Chaoyang district of China's capital. Photo: Handout The academy's strategic partnership with BJU would also be extended to detecting various chronic diseases, such as osteoporosis and severe fatty liver disease, to address the healthcare challenges of China's ageing population
South China Morning Post
14 hours ago
- South China Morning Post
Chinese city orders real-name registration for chikungunya fever medication amid outbreak
The southern city of Foshan has required real-name registration for medication to treat chikungunya fever , while two cities in southeastern China have asked travellers returning from affected areas to monitor their health for signs of the mosquito-borne illness. The market supervision bureau in Foshan, Guangdong province issued a public notice on Sunday asking all retail pharmacies to start real-name registration and to keep records when selling medications to treat symptoms of chikungunya, including fever, rashes and joint pain. This practice was also used during the Covid-19 pandemic to help mainland Chinese authorities track potential cases that were not reported. Chikungunya fever is a viral disease transmitted by the Aedes mosquito. It cannot be contracted through direct contact with another person. While rarely fatal, the illness can lead to debilitating symptoms lasting weeks. Those who buy the medications are required to provide their personal information and tell pharmacies about any recent mosquito bites or chikungunya symptoms, according to the notice. Some health authorities in Foshan have handed out administrative penalties for businesses that fail to promptly eliminate mosquito breeding sites, such as hotels and restaurants, according to state-run news site on Tuesday.
South China Morning Post
a day ago
- South China Morning Post
China's Hainan eyes medical tourism boom after South Korea axes cosmetic surgery tax perks
China's tropical island province of Hainan is accelerating its push to become a leading medical tourism hub , aiming to attract more nationals to use local healthcare services instead of seeking treatment abroad – after South Korea announced plans to scrap tax rebates for foreigners undergoing cosmetic surgery. The popular tourist destination in southern China plans to draw more than 1.5 million domestic medical tourists annually by 2027, up from the current level of over 400,000, according to a local government document issued on Monday. Hainan has also pledged to reverse the outflow of overseas medical consumption. It aims to approve two to four real-world research pilot products for domestic market entry each year and introduce at least 40 international innovative drugs and medical devices annually. In the first quarter of 2025, institutions in Hainan's special medical tourism zone welcomed 111,500 visitors seeking treatment, up 29.8 per cent year on year, the state-owned People's Daily reported last month. The use of licensed drugs and medical devices reached 16,000 people during the same period – a 44.14 per cent rise from a year earlier, according to the report. The push came as South Korea – a top competitor in medical tourism – risks losing its appeal due to a policy change announced on July 31. The new regulation, which takes effect next year, will remove value-added tax refunds for foreign tourists using medical beauty services.
